These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 27955666

  • 21. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.
    Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R.
    Br J Psychiatry; 1999 Dec; 175():576-80. PubMed ID: 10789357
    [Abstract] [Full Text] [Related]

  • 22. Severe neutropenia unrelated to clozapine in patients receiving clozapine.
    Taylor D, Vallianatou K, Gandhi S, Casetta C, Howes O, MacCabe J.
    J Psychopharmacol; 2024 Jul; 38(7):624-635. PubMed ID: 39041349
    [Abstract] [Full Text] [Related]

  • 23. [Ten years of clinical experience with clozapine about 170 patients].
    Levoyer D, Martinet JP, Badiche A, Millet B.
    Encephale; 2004 Jul; 30(3):285-95. PubMed ID: 15235527
    [Abstract] [Full Text] [Related]

  • 24. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ, Cho MJ, Oh JT, Lee Y, Chae BJ, Ko J.
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [Abstract] [Full Text] [Related]

  • 25. Hematological adverse events in clozapine-treated children and adolescents.
    Gerbino-Rosen G, Roofeh D, Tompkins DA, Feryo D, Nusser L, Kranzler H, Napolitano B, Frederickson A, Henderson I, Rhinewine J, Kumra S.
    J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
    [Abstract] [Full Text] [Related]

  • 26. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
    Tiihonen J, Tanskanen A, Bell JS, Dawson JL, Kataja V, Taipale H.
    Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
    [Abstract] [Full Text] [Related]

  • 27. [Granulocytopenia while using clozapine: continuing or stopping treatment].
    Bogers JP.
    Tijdschr Psychiatr; 2007 May; 49(8):575-9. PubMed ID: 17694491
    [Abstract] [Full Text] [Related]

  • 28. Increase in white cell and neutrophil counts during the first eighteen weeks of treatment with clozapine in patients admitted to a long-term psychiatric care inpatient unit.
    Capllonch A, de Pablo S, de la Torre A, Morales I.
    Rev Psiquiatr Salud Ment (Engl Ed); 2018 May; 11(2):94-100. PubMed ID: 27156787
    [Abstract] [Full Text] [Related]

  • 29. Morning pseudoneutropenia during clozapine treatment.
    Esposito D, Aouillé J, Rouillon F, Limosin F.
    World J Biol Psychiatry; 2003 Oct; 4(4):192-4. PubMed ID: 14608591
    [Abstract] [Full Text] [Related]

  • 30. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
    McKee JR, Wall T, Owensby J.
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
    [Abstract] [Full Text] [Related]

  • 31. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results.
    Ahn YM, Jeong SH, Jang HS, Koo YJ, Kang UG, Lee KY, Kim YS.
    Int Clin Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 15076018
    [Abstract] [Full Text] [Related]

  • 32. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.
    Remington G, Lee J, Agid O, Takeuchi H, Foussias G, Hahn M, Fervaha G, Burton L, Powell V.
    Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070
    [Abstract] [Full Text] [Related]

  • 33. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U, Sanchez P, Hernandez R, Elizagarate E.
    J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
    [No Abstract] [Full Text] [Related]

  • 34. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E, Taylor D.
    CNS Drugs; 2007 Dec; 21(1):25-35. PubMed ID: 17190527
    [Abstract] [Full Text] [Related]

  • 35. Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.
    van der Weide K, Loovers H, Pondman K, Bogers J, van der Straaten T, Langemeijer E, Cohen D, Commandeur J, van der Weide J.
    Pharmacogenomics J; 2017 Oct; 17(5):471-478. PubMed ID: 27168101
    [Abstract] [Full Text] [Related]

  • 36. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
    Meged S, Stein D, Sitrota P, Melamed Y, Elizur A, Shmuelian I, Gazit E.
    Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
    [Abstract] [Full Text] [Related]

  • 37. Clozapine-associated neutropenic enterocolitis.
    Beck DA, Miller DD.
    Ann Clin Psychiatry; 1994 Sep; 6(3):185-8. PubMed ID: 7881499
    [Abstract] [Full Text] [Related]

  • 38. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G.
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [Abstract] [Full Text] [Related]

  • 39. Neutropenia induced by second generation antipsychotics: a prospective investigation.
    Rettenbacher MA, Hofer A, Kemmler G, Fleischhacker WW.
    Pharmacopsychiatry; 2010 Mar; 43(2):41-4. PubMed ID: 20175050
    [Abstract] [Full Text] [Related]

  • 40. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW, Bogers JP, Giltay EJ.
    Gen Hosp Psychiatry; 2013 Mar; 35(5):576.e11-2. PubMed ID: 23395419
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.